ICU MEDICAL INC/DE Business Acquisition, Pro Forma Net Income (Loss)
ICU MEDICAL INC/DE (ICUI) reported Business Acquisition, Pro Forma Net Income (Loss) of -$13.21 million for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss · last filed 2023-11-06
- ICU MEDICAL INC/DE business acquisition, pro forma net income (loss) for the quarter ending 2023-09-30 was -$13.21M.
- ICU MEDICAL INC/DE business acquisition, pro forma net income (loss) for the quarter ending 2023-06-30 was -$7.47M.
- ICU MEDICAL INC/DE business acquisition, pro forma net income (loss) for the quarter ending 2023-03-31 was -$34.99M.
- ICU MEDICAL INC/DE business acquisition, pro forma net income (loss) for the quarter ending 2022-12-31 was -$15.45M, a 200.12% decline year-over-year.
- ICU MEDICAL INC/DE business acquisition, pro forma net income (loss) for fiscal 2022 was -$70.29M, a 287.66% decline from fiscal 2021.
- ICU MEDICAL INC/DE business acquisition, pro forma net income (loss) for fiscal 2021 was $37.45M.
- ICU MEDICAL INC/DE business acquisition, pro forma net income (loss) for fiscal 2017 was $91.00K, a 8.08% decline from fiscal 2016.
- ICU MEDICAL INC/DE business acquisition, pro forma net income (loss) for fiscal 2016 was $99.00K.
| Period end | Business Acquisition, Pro Forma Net Income (Loss) 3 month | Business Acquisition, Pro Forma Net Income (Loss) 6 month | Business Acquisition, Pro Forma Net Income (Loss) 9 month | Business Acquisition, Pro Forma Net Income (Loss) 12 month | Business Acquisition, Pro Forma Net Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|
| 2023-09-30 | -$13.21M 10-Q · filed 2023-11-06 | -$20.68M derived: sum of 2 quarters · filed 2023-11-06 | -$54.84M 10-Q · filed 2023-11-06 | -$71.12M derived: sum of 4 quarters · filed 2023-11-06 | |
| 2023-06-30 | -$7.47M 10-Q · filed 2023-08-07 | -$59.42M 10-Q · filed 2023-08-07 | -$57.91M derived: sum of 3 quarters · filed 2023-08-07 | -$71.12M derived: sum of 4 quarters · filed 2023-08-07 | |
| 2023-03-31 | -$34.99M 10-Q · filed 2023-05-09 | -$50.44M derived: sum of 2 quarters · filed 2023-05-09 | -$63.65M derived: sum of 3 quarters · filed 2023-05-09 | -$71.12M derived: sum of 4 quarters · filed 2023-05-09 | |
| 2022-12-31 | -$15.45M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | -$28.65M derived: sum of 2 quarters · filed 2023-02-27 | -$36.13M derived: sum of 3 quarters · filed 2023-02-27 | -$70.29M 10-K · filed 2023-02-27 | |
| 2022-09-30 | -$13.21M 10-Q · filed 2022-11-07 | -$20.68M derived: sum of 2 quarters · filed 2022-11-07 | -$54.84M 10-Q · filed 2022-11-07 | -$40.25M derived: sum of 4 quarters · filed 2023-02-27 | |
| 2022-06-30 | -$7.47M 10-Q · filed 2022-08-09 | -$59.42M 10-Q · filed 2022-08-09 | -$27.04M derived: sum of 3 quarters · filed 2023-02-27 | -$35.91M derived: sum of 4 quarters · filed 2023-02-27 | |
| 2022-03-31 | -$34.99M 10-Q · filed 2022-05-09 | -$19.57M derived: sum of 2 quarters · filed 2023-02-27 | -$28.44M derived: sum of 3 quarters · filed 2023-02-27 | $5.80M derived: sum of 4 quarters · filed 2023-02-27 | |
| 2021-12-31 | $15.43M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $6.55M derived: sum of 2 quarters · filed 2023-02-27 | $40.80M derived: sum of 3 quarters · filed 2023-02-27 | $37.45M 10-K · filed 2023-02-27 | |
| 2021-09-30 | -$8.87M 10-Q · filed 2022-11-07 | $25.37M derived: sum of 2 quarters · filed 2022-11-07 | $22.03M 10-Q · filed 2022-11-07 | ||
| 2021-06-30 | $34.24M 10-Q · filed 2022-08-09 | $31.45M 10-Q · filed 2022-08-09 | |||
| 2021-03-31 | -$1.99M 10-Q · filed 2022-05-09 | ||||
| 2017-12-31 | $91.00K 10-K · filed 2020-03-02 | $1.42M 10-K · filed 2018-03-16 | |||
| 2016-12-31 | $99.00K 10-K · filed 2019-03-01 | $22.00K 10-K · filed 2018-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |